Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GentiBio
Biotech
Prothena promotes one exec while another leaves—Chutes & Ladders
Prothena promotes one exec while another leaves. Metsera makes big moves in supplier and C-suite. Allarity pulls two Lilly vets.
Darren Incorvaia
,
Zoey Becker
Oct 4, 2024 8:00am
BMS sold on GentiBio's regulatory T-cells, inks $1.9B deal
Aug 10, 2022 7:00am
GentiBio banks $157M to fuel Treg treatment for Type 1 diabetes
Aug 11, 2021 6:00am